Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
Nintedanib Impurity 28 REF: 4Z-N-066044CAS: 855860-75-2	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 54 REF: 4Z-L-124061	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 53 REF: 4Z-L-124060	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 29 REF: 4Z-L-124034	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 79 REF: 4Z-P-196089CAS: 2768689-12-7 571189-64-5	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 51 REF: 4Z-L-124058	- - -	To inquire	Tue 10 Dec 24
Gimeracil Impurity 12 REF: 4Z-G-047014	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 52 REF: 4Z-L-124059	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 89 REF: 4Z-N-066102	- - -	To inquire	Tue 10 Dec 24
Sodium Dichloroisocyanurate REF: 4Z-G-047022CAS: 1260366-40-2 2782-57-2 2893-78-9	- - -	To inquire	Tue 10 Dec 24
N1-Nitroso Levofolinic Acid REF: 4Z-F-068031	- - -	To inquire	Tue 10 Dec 24
Folinic Acid Impurity 5 (4-Aminobenzoyl D-Glutamic Acid) REF: 4Z-F-068014CAS: 5959-18-2	- - -	To inquire	Tue 10 Dec 24
Folinic Acid Impurity 14 REF: 4Z-F-068033	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 103 REF: 4Z-N-066117CAS: 2653-16-9	- - -	To inquire	Tue 10 Dec 24
Folinic Acid Impurity 13 REF: 4Z-F-068032	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 47 REF: 4Z-E-068060CAS: 2029195-97-7	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 17 (Intedanib Impurity 17) REF: 4Z-N-066031	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 55 REF: 4Z-L-124062CAS: 205448-66-4	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 40 REF: 4Z-N-066058CAS: 78466-25-8	- - -	To inquire	Tue 10 Dec 24
N-Nitroso Palbociclib Impurity 11 REF: 4Z-P-196086	- - -	To inquire	Tue 10 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Nintedanib Impurity 28

Ref: 4Z-N-066044

Lenvatinib Impurity 54

Ref: 4Z-L-124061

Lenvatinib Impurity 53

Ref: 4Z-L-124060

Lenvatinib Impurity 29

Ref: 4Z-L-124034

Palbociclib Impurity 79

Ref: 4Z-P-196089

Lenvatinib Impurity 51

Ref: 4Z-L-124058

Gimeracil Impurity 12

Ref: 4Z-G-047014

Lenvatinib Impurity 52

Ref: 4Z-L-124059

Nintedanib Impurity 89

Ref: 4Z-N-066102

Sodium Dichloroisocyanurate

Ref: 4Z-G-047022

N1-Nitroso Levofolinic Acid

Ref: 4Z-F-068031

Folinic Acid Impurity 5 (4-Aminobenzoyl D-Glutamic Acid)

Ref: 4Z-F-068014

Folinic Acid Impurity 14

Ref: 4Z-F-068033

Nintedanib Impurity 103

Ref: 4Z-N-066117

Folinic Acid Impurity 13

Ref: 4Z-F-068032

Enzalutamide Impurity 47

Ref: 4Z-E-068060

Nintedanib Impurity 17 (Intedanib Impurity 17)

Ref: 4Z-N-066031

Lenvatinib Impurity 55

Ref: 4Z-L-124062

Nintedanib Impurity 40

Ref: 4Z-N-066058

N-Nitroso Palbociclib Impurity 11

Ref: 4Z-P-196086